CD44 and nonpapillary renal cell carcinoma: Next, we evaluated the expression of CD44 in tumors consisting of ccRCC cell line Caki-1 and detected higher protein expression of CD44 in tumors containing the MCPIP1 mutation (pLIX D141N) than in control tumors (pLIX PURO) (Fig. 7D).